Anticancer Medications

  • Neotrexate Tablets

    Neotrexate Tablets (Generic Methotrexate) Methotrexate is used for the treatment of wide range of cancers of the breast, skin, head and neck or lung. It is also used to treat severe psoriasis and rheumatoid arthritis. Methotrexate is usually given after other medications have been tried without successful treatment of symptoms. Neotrexate  is an antimetabolite and antifolate drug. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, Eczema, Lymphoma, Trophoblastic Disease and for the induction of medical abortions. .

    0.00 $
  • Axitinib (Inlyta)

    Axitinib is a medicine used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC) when one prior drug treatment for this disease has not worked or has stopped working.You may also have it as part of a clinical trial for other cancers including soft tissue sarcoma and thyroid cancer.

    290.00 $
  • Zitiga (abiraterone)

    Active substance: Abirateronum Generic name: Xbira Packaging: 1 bank of 250 mg X 120 tabs Manufacturer: Cilpa/India Indications: Abiraterone is a type of hormone therapy. It is also called abiraterone acetate, CB7630 or Zytiga. It is used to treat prostate cancer that has spread to other parts of the body. Clinical trials are also using abiraterone for earlier stages of prostate cancer and advanced breast cancer.

    1 224.00 $
  • Iressa (Gefitinib)

    Active substance: Gefitinibum Generic name: Geftinat Packaging: 250 mg / 30 tabs Manufacturer: Natco/india Indications: Approved for the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) whose tumors contain specific types of epidermal growth factor receptor (EGFR) gene mutations. A companion test is now approved to identify such appropriate patients. It is a treatment for non small cell lung cancer that has spread into surrounding tissues (locally advanced cancer) or to other parts of the body. Gefitinib is also used in clinical trials for other types of cancer.

    335.00 $
  • Bondronat (Ibandronic acid)

    Active substance: Each film-coated tablet contains 50 mg of ibandronic acid (as sodium monohydrate) Generic name: Bandrone Packaging: 50 mg / tablet 28 Manufacturer: Pfizer/india Indications: Bondronat is indicated in adults for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.

    86.00 $
  • Gleevec (Imatinib)

    Chronic myeloid leukaemia Gastro Intestinal Stromal Tumour (GIST) – a rare type of stomach cancer Acute lymphoblastic leukaemia that is Philadelphia chromosome positive A rare type of sarcoma called dermatofibrosarcoma protuberans Adults with myelodysplastic disorders Adults with myeloproliferative disorders Adults with advanced HES (hypereosinophilic syndrome) or chronic eosinophilic leukaemia

    115.00 $
  • Crizotinib (crizalk)

    Active substance: Tacrolimusum Generic name: Crizalk Packaging: 250 mg / 60 capsules Manufacturer: Pfizer/india Indications: Common non-small cell lung cancer (NSCLC), anaplastic lymphoma kinase expression (ALK).

    356.00 $
  • Xeloda (capecitabine)

    Active substance: Capecitabine Generic name: Xeloda Packaging: 500 mg / 120 tablet Manufacturer: Roche/india Indications: Breast cancer (locally advanced or metastatic). Monotherapy - ineffectiveness of chemotherapy drugs from the group of taxanes (paclitaxel) or anthracyclines, or with contraindications to chemotherapy with anthracyclines. Combination therapy with docetaxel - ineffectiveness of chemotherapy drugs including anthracyclines. Colon cancer (metastatic).

    670.00 $
  • Tykerb (lapatinib)

    Active substance: Lapatinib Generic name: Tykerb Packaging: 250 mg / 70 tabs Manufacturer: Glaxosmith /india Indications: to be given in combination with Xeloda (chemical name: capecitabine), a type of chemotherapy, to treat advanced-stage, HER2-positive breast cancer that has stopped responding to anthracyclines, taxanes, and Herceptin to be given in combination with Femara (chemical name: letrozole), a type of hormonal therapy, to treat postmenopausal women diagnosed with hormone-receptor-positive, HER2-positive metastatic breast cancer

    1 050.00 $
  • Votrient (Pazopanib) Хит
    Votrient (Pazopanib)

    Active substance: Pazopanibum Generic name: Revolade Packaging: 200 mg / 30 tabs Manufacturer: Novartis Indications: Treatment of advanced renal cell carcinoma (RCC)

    290.00 $
  • Tarceva (erlotinib)

    Active substance: Erlotinib hydrochloride Generic name: Erlotinib Packaging: Capsules of 150 mg / 30 tabs Manufacturer: Cilpa/India Indications: locally advanced or metastatic non-small cell lung cancer after failure of one or more chemotherapy regimens; first-line treatment of locally advanced, unresectable or metastatic pancreatic cancer in combination with gemcitabine.

    266.00 $
  • Nexavar (Sorafenib)

    Active substance: Sorafenib Generic name: Sorafenib Packaging: 1 tub of 200 mg / 30 tablets Manufacturer: Natco/india Indications: metastatic renal cell carcinoma - primary kidney cancer advanced primary liver cancer (hepatocellular carcinoma). Thyroid cancer (radioactive iodine resistant advanced thyroid carcinoma.)

    105.00 $
  • Evertor (Everolimus)

    Active substance: Everolimus Generic name: Evertor Packaging: 1 блистер X 10 таблеток/10мг Manufacturer: Biocon/india Indications: Everolimus is approved for various conditions: Advanced kidney cancer (approved in March 2009) Prevention of organ rejection after renal transplant(April 2010) Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) in patients who are not suitable for surgical intervention (October 2010) Progressive or metastatic pancreatic neuroendocrine tumors not surgically removable (May 2011) Breast cancer in post-menopausal women with advanced hormone-receptor positive, HER2-negative type cancer, in conjunction with exemestane (July 2012) Prevention of organ rejection after liver transplant(Feb 2013)

    1 030.00 $
  • Tasigna (Nilotinib)

    Active substance: Nilotinib Generic name: Tasigna Packaging: 28 tabs/200mg Manufacturer: Novartis/India Indications: - Treatment of Philadelphia, chromosome-positive, chronic myeloid leukemia, in chronic phase and accelerated phase, in adult patients intolerant or resistant to prior therapy, including imatinib.

    451.00 $
  • Revlimid (Lenalidomide)

    Active substance: Lenalidomide Generic name: Lenalid 10 Packaging: Capsules of 5 mg / 10 mg / 15 mg / 25 mg Manufacturer: Natco/India Indications: Treatment (in combination with dexamethasone) of multiple myeloma for patients who have received at least one line of therapy.Lenalidomide is used to treat people with myelodysplastic syndromes (MDS).

    105.00 $
  • Revoleyd (Eltrombopag)

    Active substance: Eltrombopag olamine. Generic name: Revolade Packaging: 50 mg / tablet 28 Manufacturer: Pfizer/India Indications: Thrombocytopenia (low platelet counts) in patients with chronic ITP who have observed insufficient response to corticosteroids, immunoglobulins and / or splenectomy. The drug Revoleyd is assigned these patients to reduce the risk of bleeding. Also indicated for patients with aplastic anemia for which immunosuppression has not been successful. In cases of severe liver cirrhosis due to HepC, revoleyd prepares the body for interferon treatment by increasing platelet count.

    830.00 $
  • Temodal (Temozolomide)

    Newly diagnosed glioblastoma multiforme, a particularly aggressive brain tumour, in adults. Temozolomide is initially used in conjunction with radiotherapy and then on its own after radiotherapy. Brain tumours (malignant gliomas) such as glioblastoma multiforme or anaplastic astrocytoma in adults or children over three years of age. Temozolomide is used when the brain tumour has come back or progressed after other standard treatment.

    160.00 $